The largest database of trusted experimental protocols

Male apoe mice

Manufactured by Jackson ImmunoResearch
Sourced in United States

Male ApoE−/− mice are genetically engineered mice that lack the apolipoprotein E (ApoE) gene. These mice are widely used in research to study atherosclerosis and lipoprotein metabolism.

Automatically generated - may contain errors

11 protocols using male apoe mice

1

ApoE Knockout Mice LPS Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male ApoE−/− mice (6 to 8 weeks old) on the C57BL/6 background were purchased from the Jackson laboratory and fed with RD or HFD. Either PBS or subclinical-dose LPS (5 ng/kg body weight) was intraperitoneally injected every 3 days for 1 month. Then, the mice were sacrificed, and tissues were harvested for further analyses. All animal procedures were in accordance with the U.S. National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the Intuitional Animal Care and Use Committee of Virginia Tech.
+ Open protocol
+ Expand
2

Tracer Biodistribution in ApoE-/- Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6J-albino mice (originally from the Jackson Laboratory, n = 16) were used to study tracers’ biodistribution and blood kinetics. Male ApoE−/− mice (originally from the Jackson Laboratory, n = 23) were infused for 4 weeks with 1000 ng/kg/min of human Ang II (Calbiochem) delivered by a subcutaneous osmotic minipump (Model 2004, Alzet), as described.35 (link) All experiments were performed in accordance with the regulations of Yale University and VA Connecticut Institutional Animal Care and Use Committees.
+ Open protocol
+ Expand
3

Atherogenic Diet-Induced Atherosclerosis in ApoE-/- Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male apoE−/− mice (age, 8 weeks, 20±2 g) bred from a C57BL/6J background were obtained from Jackson Laboratory (Peking University Health Science Center, Beijing, China). Mice (n=16) were fed a high-fat, cholesterol-rich atherogenic diet containing 21% fat, 19.5% casein and 1.25% cholesterol for 4 weeks and during the course of the experiment, all mice were allowed ad libitum access to food and water. They were maintained at 20–24°C with 45–55% humidity with a 12-h light-dark cycle. The mice were divided into two groups: MCP (n=8) and model (n=8) groups. A total of 1% MCP (Centrax International Corporation, San Francisco, USA) was added into the drinking water of the mice in the MCP group, for 4 weeks. All animal protocols were approved by the Animal Ethics Committee of the Beijing Institute of Geriatrics (Beijing, China).
+ Open protocol
+ Expand
4

Apolipoprotein E Knockout Mouse Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
The studies were approved by the Cedars-Sinai Institutional Animal Care and Use Committee. Male apoE−/−mice were purchased from Jackson Laboratory at 6 weeks of age and housed in a specific pathogen-free facility, kept on a 12-h day/night cycle, and had unrestricted access to water and food.
+ Open protocol
+ Expand
5

Angiotensin II-Induced Atherosclerosis Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male apoE (-/-) mice (Jackson Laboratories, Bar Harbor, ME) were housed in a pathogen-free animal facility, fed normal chow, and kept on a 12-hour day/night cycle with ad libitum access to food and water. At 10 weeks of age, an osmotic pump (Alzet model 2004, DURECT Corporation, Cupertino, CA) was subcutaneously implanted under anesthesia in the back to continuously infuse AngII (Sigma-Aldrich, St. Louis, MO) at a dose of 1000ng/Kg/min for 4 weeks [9 (link), 10 (link)]. Analgesic was injected subcutaneously prior to the pump implantation to alleviate post-procedure pain. Mice were observed post implantation for recovery from anesthesia and pump implantation under a heat lamp. Mice were checked daily for the duration of the experiment. For the immunization study, a separate group of mice were subcutaneously immunized with p210/cBSA/Alum conjugate in the dorsal area at 7 weeks of age, followed by a booster at 10 and 12 weeks of age [7 (link), 8 (link)]. Mice receiving cBSA/alum or PBS served as control groups. AngII pump implantation was performed on the mice at 10 weeks of age, as described above. Mice were sacrificed at 14 weeks of age. The method of euthanasia was overdose of inhalational anesthesia followed by pneumothorax to assure death.
+ Open protocol
+ Expand
6

Therapeutic siRNA nanoparticles in ApoE-/- mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male ApoE−/− mice (4–6 weeks old; Jackson Laboratory, Bar Harbor, ME, USA) were fed a Western diet (TD.88137; Envigo, Huntingdon, UK) for 14 weeks before treatment with p5RHH-JNK2 siRNA nanoparticles at 0.5 mg siRNA/kg or HBSS via tail-vein injection for 3.5 weeks, with a total of seven doses. During treatment, all mice were maintained on the Western diet. Animals were killed 24 hours after the final dose.
+ Open protocol
+ Expand
7

ApoE-/- Mice Fondaparinux Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male ApoE -/-mice were purchased from The Jackson Laboratory and placed on a lard-containing diet comprising 21% lard and 0.15% added cholesterol at 6 weeks of age. All mice were housed in the same room and exposed to the same light-dark cycle and diet. Mice were housed at no more than four mice per cage. At 20 weeks of age, mice were divided into 2 groups (12 mice per group): disease control group and fondaparinux treatment group. Fondaparinux was intraperitoneally administered at a dose of 5 mg • kg -1 • day -1 according to body weight from week 20 to 24. 14 In the control group, the same volume of 0.9% saline was intraperitoneally injected with the same intervals.
+ Open protocol
+ Expand
8

PAR-2 Deficiency in ApoE-/- Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
The research was approved by the Local Animal Ethics Committee of Southeast University. The housing and care of animals and all the procedures done in the study were performed in accordance with the guidelines and regulations of the local Animal Ethics Committee of Southeast University. PAR-2-/- female mice (Jackson Laboratory, Bar Harbor, ME, United States), at least 5 generations backcrossed to C57BL/6, were outcrossed to ApoE-/- male mice (Jackson Laboratory, Bar Harbor, ME, United States), which had been backcrossed 11 generations to C57BL/6. PAR-2 wild-type and PAR-2-/- mice among ApoE-/- mice were designated as Control and PAR-2-/-, respectively. Male Control and PAR-2-/- mice were fed a lard-containing diet comprising 21% lard and 0.15% added cholesterol for 12 weeks starting at 6 weeks of age. All mice were housed in the same room and exposed to the same light dark cycle.
+ Open protocol
+ Expand
9

Dietary Effects on Lipoprotein Metabolism

Check if the same lab product or an alternative is used in the 5 most similar protocols
WT and Apoe−/− male mice, both of a C57BL/6J genetic background, were purchased from The Jackson Laboratory (Bar Harbor, ME, USA) and maintained on a 12 h light/dark cycle at room temperature. Animals were fed ad libitum with a STD (5.3% calories from fat; D.Rod18.H07, LASvendi GmbH, Soest, Germany) or HFD (60% calories from fat; TD 06414, Envigo Teklad, Barcelona, Spain) from weaning until euthanasia at 8 or 18 weeks. For each period of study, three groups (5-14 mice/group) were established: STD-fed WT, STD-fed Apoe−/− and HFD-fed Apoe−/−. Sacrifice of 16 h-fasted mice was performed after 8 or 18 weeks on the respective diets. All animal experimentation was conducted in accordance with the accepted standards of animal use approved by the Complutense University of Madrid Committee.
+ Open protocol
+ Expand
10

Angiotensin II-Induced Aortic Aneurysm Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Osmotic infusion pump (Alzet® 1004, Durect Corp., C upertino, California) containing 1000 ng/kg/min of Ang II was implanted subcutaneously into 20 ApoE −/− male mice (Jackson Laboratory, Bar Harbor, ME) on a high fat diet introduced one week prior to the day of surgery as previously described.16 (link),18 (link)–20 (link) In the Ang II control group, mice (n=28) received PBS intravenously once a day from the day of surgery (day 0) to the day of harvest (day 3 or day 28). In the RvD1 treated group, mice (n=25 mice) received RvD1 once a day from the day of the surgery (day 0) to the day of harvest (days 3 or day 28).
Mice were euthanized under anesthesia by overdose and exsanguination. The abdominal aorta was fully dissected and video micrometry measurements of the maximum aortic diameter were performed using NIS-Elements D.3.10 software attached to the microscope (Nikon SMX- 800, Melville, NY). On postoperative days 3 or 28, aortic samples were then flash-frozen and used for cytokine analysis (n=9–10/group/day28). Any mouse that died prior to the study endpoint underwent autopsy to determine cause of death. One day 3 mouse in the RvD1 treated group died during the injection process and one day 28 mouse in the Ang II group died of aortic rupture.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!